Padcev 20 mg lyophilized powder for injection Images
Generic Name: enfortumab vedotin
This medication has been identified as Padcev 20 mg lyophilized powder for injection. It is supplied by Astellas Pharma US, Inc.
Padcev is used in the treatment of Urothelial Carcinoma; Bladder Cancer and belongs to the drug class miscellaneous antineoplastics. Padcev 20 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Padcev
- Generic Name
- enfortumab vedotin
- Strength
- 20 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Astellas Pharma US, Inc.
- National Drug Code (NDC)
- 51144-0020
More about Padcev (enfortumab vedotin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
